BrainFulness

Develops a device and software for repetitive triggered somatosensory discrimination to enhance neurological outcomes, as a treatment for major depression.

Health Tech & Life Sciences
Active
Pre-Funding Jerusalem, Israel Founded 2013
Last updated 2026-07-20
Total raised
$55K
Last: Grant 2015-12
Stage
Pre-Funding
Founded
2013
Headcount
3
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

BrainFulness has developed a new technology for treating major depression, ADHD, and dementia with no side effects. The company has built a working prototype of its technology and registered for patents in Israel, the United States, Germany, and Japan. The prototype was approved for human use by the Israeli Health Ministry, and BrainFulness has completed a clinical trial on chronic, treatment-resistant patients, yielding encouraging results without side effects. The device is a low-cost, innovative, non-invasive device for home treatment of major depression and chronic anxiety, based on Repetitive Triggered Somatosensory Discrimination (RTSD) technology.

Funding history · 1 round · $55K total

2015-11
Grant $55K

Headcount over time

From 2 (2018-12) to 3 (2023-12) · +1 (+50%) · 5 points · source: Finder history + radar grounding
40 2018-12 2023-12

Q&A

What is BrainFulness's primary focus?
BrainFulness focuses on developing new technology for treating major depression, ADHD, and dementia without side effects.
When was BrainFulness founded?
BrainFulness was founded in September 2015.
What is the current employee count for BrainFulness?
BrainFulness has 1-10 employees.
Has BrainFulness secured any funding?
Yes, BrainFulness received a Grant round of $55,000 in December 2015 from Israel Innovation Authority.
What is BrainFulness's current funding stage?
BrainFulness is currently in the Pre-Funding stage.
Has BrainFulness registered any patents?
Yes, BrainFulness has registered for patents in Israel, the United States, Germany, and Japan.
Has BrainFulness conducted clinical trials?
BrainFulness has completed a clinical trial on chronic, treatment-resistant patients, yielding encouraging results without side effects, after its prototype was approved for human use by the Israeli Health Ministry.
Who are the founders of BrainFulness?
The founders of BrainFulness are Prof. Haim Knobler and Abraham Shoshani.

Team · 4

Haim Knobler
Founder · Founder & Advisor
Abraham Shoshani
Founder · Founder & Director
Gerard Henzen
Founder · Co-Founder
Shoshani Avi
Founder · Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2C

Highlights

1 PatentsVerified

Tags

medical-devicesmental-healthpatientsnon-invasiveconsumers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitebrainfulnessltd.com/
LinkedInlinkedin.com/company/11830501
Facebookfacebook.com/pages/category/Biotechnology-Company/Brainfulne

Identifiers & details

Founded2013
Employees (exact)3

Radar intelligence

Web history (Wayback)

Domainbrainfulnessltd.com

Certificate / subdomain footprint

Subdomains3

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515322899
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2015-11-25
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events4 — annual_report (3), violation (1)
Registered addressאגמון 2 ירושלים

Recent registry events

DateEvent
2025-08-11דו~ח שנתי
2025-08-04עדכון הפרה
2026-06-03דו~ח שנתי-הקצאת מניות
2026-06-03דו~ח שנתי-עדכון בעלי מניות